Rypdal, K. B., Erusappan, P. M., Melleby, A. O., Seifert, D. E., Palmero, S., Strand, M. E., . . . Lunde, I. G. (2021). The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts. Nature Portfolio.
Cita Chicago Style (17a ed.)Rypdal, Karoline B., et al. The Extracellular Matrix Glycoprotein ADAMTSL2 Is Increased in Heart Failure and Inhibits TGFβ Signalling in Cardiac Fibroblasts. Nature Portfolio, 2021.
Cita MLA (8a ed.)Rypdal, Karoline B., et al. The Extracellular Matrix Glycoprotein ADAMTSL2 Is Increased in Heart Failure and Inhibits TGFβ Signalling in Cardiac Fibroblasts. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.